Eli Lilly partnered with IQVIA to speed clinical trial design by extracting and analyzing oncology and diabetes trial data more efficiently. Using IQVIA’s NLP platform, they automated text mining from ClinicalTrials.gov and TrialTrove, converting unstructured records into structured, comparable datasets. This eliminated tedious manual processes, reduced errors, and cut costs, while improving precision and recall of trial endpoints. Researchers gained rapid access to efficacy metrics and insights, enabling faster competitor analysis, informed payer discussions, and optimized trial planning. The solution accelerated research timelines, supporting quicker, more cost-effective drug development.

Join for free to read